The FDA recently authorized the sale of four menthol-flavored NJOY products from Altria. NJOY could help the company return to revenue growth. The stock is inexpensive with a robust dividend that is ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. Days after exiting its stake in troubled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results